AZD5363 in combination with fulvestrant in AKT1-mutant ER-positive metastatic breast cancer Meeting Abstract


Authors: Smyth, L. M.; Oliveira, M.; Ciruelos, E.; Tamura, K.; El-Khoueiry, A.; Mita, A.; You, B.; Renouf, D. J.; Sablin, M. P.; Lluch, A.; Mayer, I. A.; Bando, H.; Yamashita, H.; Ambrose, H.; de Bruin, E.; Carr, T. H.; Corcoran, C.; Foxley, A.; Lindemann, J. P. O.; Maudsley, R.; Pass, M.; Rutkowski, A.; Schiavon, G.; Banerji, U.; Scaltriti, M.; Taylor, B. S.; Chandarlapaty, S.; Baselga, J.; Hyman, D. M.
Abstract Title: AZD5363 in combination with fulvestrant in AKT1-mutant ER-positive metastatic breast cancer
Meeting Title: 40th Annual San Antonio Breast Cancer Symposium (SABCS 2017)
Journal Title: Cancer Research
Volume: 78
Issue: 4 Suppl.
Meeting Dates: 2017 Dec 5-9
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2018-02-01
Language: English
ACCESSION: WOS:000425489402066
PROVIDER: wos
DOI: 10.1158/1538-7445.SABCS17-P5-21-32
Notes: Meeting Abstract: P5-21-32 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. David Hyman
    354 Hyman
  2. Barry Stephen Taylor
    238 Taylor
  3. Jose T Baselga
    484 Baselga
  4. Maurizio Scaltriti
    170 Scaltriti
  5. Lillian   Smyth
    42 Smyth